SBIR/STTR Research Award
Development and evaluation of an all-in-one integrated webbased buprenorphine treatment program for opioid use disorder (Digital Interventions for Opioid Disorders- DIOD)
Award amount
$224,535Program and phase
SBIR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- WORKIT HEALTH INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- C6TNWKSNHUN4
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
Workit Health will develop an automated system that helps clinicians organize and analyze patient dataPatients will express higher rates of treatment adherence in Medication Assisted Treatment in conjunction with psychosocial supportWorkit Health will conduct a randomized clinical trial that combines psychosocial support through CBT modules and peercounselor support and the DIOD program which adds access to a clinician providing telemedicine MATIt is hypothesized that patients receiving both elements will demonstrate up togreater adherence in treatment and significant gains in self reported quality of lifeas well as reduced drug use
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- DEVELOPMENT OF A FULLY-INTEGRATED CHATBOT TO IMPROVE MEMBER ENGAGEMENT IN ONLINE ADDICTION TREATMENT PROGRAMS
- SBIR Phase I: An Automated Tool to Measure and Predict Substance Use Recovery
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
3 SBIR/STTR records share this UEI (2017–2021). Reported award amounts total $763,539. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services, National Science Foundation